title: Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda
source: SeekingAlpha
date: 2025-10-24
url: https://finnhub.io/api/news?id=94f6db346ac6041cafc9b21d9be4eb789d748bc3f96b578c050eadc169240b26
Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock prospects ahead of the new data.
